 |
|
|
|
|
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Casebia Therapeutics
| | | | | Year Established: | 2016 | | Main Contact: | James W. Burns, Ph.D., President & CEO | | | | Company Description | | Casebia, a joint venture of Bayer and CRISPR Therapeutics, is a novel joint venture focused on the development of breakthrough therapies using the promising CRISPR/Cas9 gene editing technology, including more advanced applications combining in vivo delivery and gene correction strategies. | |
|
|
|
|
|
|
|
